19.70
—
Close of 4 Nov 2026, in SAR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Almujtama Alraida Medical Co SJSC
Its shares trade on Tadawul under the ticker 9592.SR. It has been listed since 22 November 2023. In the fiscal year to 31 December 2025, it reported revenue of SAR 454.7m and net income of SAR 8.4m. At that date it held total assets of SAR 515.1m and shareholders' equity of SAR 126.3m.
Almujtama Alraida Medical Co SJSC is a SA-based company operating in industry. Al-Mujtama Al-Raida Medical Company SJSC is a Saudi Arabia-based company, which operates in pharmaceutical services. The Company’s core operations include operating pharmacies and retail in pharmaceutical products such as medicines and cosmetic products and medical equipment and medical supplies.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 22 Nov 2023
- Employees
- 750
- Website
- almujtama.com.sa ↗
Leadership
Pay as last reported
- Mr. Omar bin Yusuf Yuldash KhojaNon-Independent Non-Executive Chairman of the Board
- Mr. Abdulaziz bin Omar Yusuf KhojaChief Executive Officer, Executive Director, since 2022
- Mr. Hisham bin Omar Ali BaroomNon-Independent Non-Executive Vice Chairman of the Board
- Mr. Rami Mamdouh MohamedFinancial Director
- Mr. Yousef bin Omar Yusuf KhojaNon-Independent Executive Director, Director - Human Resources Department, since 2019
- Mr. Ahmed Fattouh Abdulaziz Al-BayaDirector - Training Department
- Mr. Mohammed Aboud BaqalaqalManager - Support Services Department
- Mr. Mohammed bin Hussein Abdul Mawla Al-FaqiDirector - Planning and Logistics Department
- Dr. Fayez Khaled Yousef GenenaDirector - Administrative Supervision Department and Director of the Wasfati Program
- Dr. Karim Mohammed Hashem MohammedPractical Office Manager
- Mr. Abdullah Abdul Hafeez KhojaDirector - Technical Supervision and Technical Support Department
- Mr. Mahmoud Musa Bater KhojaDirector - Warehouse Management
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Operates pharmacies and retail in pharmaceutical products including medicines, cosmetics, and medical equipment.
- Has a clear focus on pharmaceutical services within the Saudi market.
- Employed 750 people as of the latest data.
Weaknesses
- Industry and sector information is listed as N/A, indicating lack of clear industry classification.
- No specific financial metrics or performance data provided for assessment.
- IPO date is 2023-11-22, suggesting a relatively new public company with limited historical data.
Opportunities
- Expanding operations in the Saudi pharmaceutical market with growing healthcare demand.
- Potential to leverage the IPO for further growth and market expansion.
- Operating in a sector with increasing demand for pharmaceutical services in Saudi Arabia.
Threats
- Unclear industry classification may hinder strategic planning and investor confidence.
- New public company status with limited historical data may deter some investors.
- Competition in the pharmaceutical retail sector could impact market share.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.